TrialTargeted oncology2020

Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).

Juan Manuel Sepúlveda-Sánchez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.